Improved methodology for the affinity isolation of human protein complexes expressed at near endogenous levels

An efficient and reliable procedure for the capture of affinity-tagged proteins and associated complexes from human cell lines is reported. Through multiple optimizations, high yield and low background affinity-purifications are achieved from modest quantities of human cells expressing endogenous-le...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:BioTechniques. - 1988. - 0(2012), 0 vom: 06. Mai, Seite 1-6
1. Verfasser: Domanski, Michal (VerfasserIn)
Weitere Verfasser: Molloy, Kelly, Jiang, Hua, Chait, Brian T, Rout, Michael P, Jensen, Torben Heick, LaCava, John
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2012
Zugriff auf das übergeordnete Werk:BioTechniques
Schlagworte:Journal Article
LEADER 01000naa a22002652 4500
001 NLM218364423
003 DE-627
005 20231224040241.0
007 cr uuu---uuuuu
008 231224s2012 xx |||||o 00| ||eng c
024 7 |a 10.2144/000113864  |2 doi 
028 5 2 |a pubmed24n0728.xml 
035 |a (DE-627)NLM218364423 
035 |a (NLM)22668517 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Domanski, Michal  |e verfasserin  |4 aut 
245 1 0 |a Improved methodology for the affinity isolation of human protein complexes expressed at near endogenous levels 
264 1 |c 2012 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 21.10.2021 
500 |a published: Print 
500 |a Citation Status PubMed-not-MEDLINE 
520 |a An efficient and reliable procedure for the capture of affinity-tagged proteins and associated complexes from human cell lines is reported. Through multiple optimizations, high yield and low background affinity-purifications are achieved from modest quantities of human cells expressing endogenous-level tagged proteins. Isolations of triple-FLAG and GFP-tagged fusion proteins involved in RNA metabolism are presented 
650 4 |a Journal Article 
700 1 |a Molloy, Kelly  |e verfasserin  |4 aut 
700 1 |a Jiang, Hua  |e verfasserin  |4 aut 
700 1 |a Chait, Brian T  |e verfasserin  |4 aut 
700 1 |a Rout, Michael P  |e verfasserin  |4 aut 
700 1 |a Jensen, Torben Heick  |e verfasserin  |4 aut 
700 1 |a LaCava, John  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t BioTechniques  |d 1988  |g 0(2012), 0 vom: 06. Mai, Seite 1-6  |w (DE-627)NLM012627046  |x 1940-9818  |7 nnns 
773 1 8 |g volume:0  |g year:2012  |g number:0  |g day:06  |g month:05  |g pages:1-6 
856 4 0 |u http://dx.doi.org/10.2144/000113864  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_22 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_65 
912 |a GBV_ILN_70 
912 |a GBV_ILN_99 
912 |a GBV_ILN_121 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
912 |a GBV_ILN_618 
912 |a GBV_ILN_640 
912 |a GBV_ILN_754 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2002 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2023 
912 |a GBV_ILN_2035 
912 |a GBV_ILN_2040 
912 |a GBV_ILN_2060 
912 |a GBV_ILN_2099 
912 |a GBV_ILN_2105 
912 |a GBV_ILN_2121 
912 |a GBV_ILN_2470 
951 |a AR 
952 |d 0  |j 2012  |e 0  |b 06  |c 05  |h 1-6